LIPID SPECTRUM CHANGES AND BLOOD PRESSURE LEVELS IN OBESE PATIENTS WITH TRUE AND PSEUDO-RESISTANT HYPERTENSION

被引：0
|
作者：
Shalimova, A. [1 ]
Isayeva, A. [2 ]
Buriakovska, O. [2 ]
Komir, I. [2 ]
Vovchenko, M. M. [2 ]
机构：
[1] Kharkiv Natl Med Univ, Internal Med N1, Kharkiv, Ukraine
[2] Natl Acad Med Sci Ukraine, LT Malaya Therapy Natl Inst, Complex Risk Reduct Chron Noncommunicable Dis, Kharkiv, Ukraine
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP370
引用
收藏
页码：E212 / E212
页数：1
相关论文
共 50 条
  • [31] POOR ACHIEVEMENT OF THE TARGET BLOOD PRESSURE LEVELS ASSOCIATED WITH DIASTOLIC HEART FAILURE IN PATIENTS WITH RESISTANT HYPERTENSION
    Rekovets, Oksana
    Sirenko, Yuriy
    Torbas, Olena
    Kushnir, Svitlana
    Primak, Galina
    JOURNAL OF HYPERTENSION, 2023, 41 : E295 - E295
  • [32] The relationship between plasma renin and aldosterone levels and the reduction of blood pressure with spironolactone in patients with resistant hypertension
    Obertynska, O.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2176 - 2176
  • [33] Effect of weight management with orlistat on blood pressure in obese patients with hypertension
    Sharma, AM
    Golay, A
    OBESITY RESEARCH, 2001, 9 : 189S - 189S
  • [34] Correlates of aortic stiffness progression in patients with resistant hypertension: importance of clinic and ambulatory blood pressure changes
    Roderjan, Christian N.
    Cardoso, Claudia R. L.
    Ferreira, Marcel T.
    Muxfeldt, Elizabeth S.
    Salles, Gil F.
    JOURNAL OF HYPERTENSION, 2015, 33 (04) : 827 - 835
  • [35] Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension
    Veglio, F
    Rabbia, F
    Riva, P
    Martini, G
    Geneva, GC
    Milan, A
    Paglieri, C
    Carra, R
    Chiandussi, L
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2001, 23 (03) : 203 - 211
  • [36] Assessment of efficacy of spironolactone in the treatment of true resistant hypertension evaluated by ambulatory blood pressure monitoring
    Souza, F.
    Salles, G.
    Fiszman, R.
    Muxfeldt, E.
    JOURNAL OF HYPERTENSION, 2008, 26 : S469 - S469
  • [37] Ambulatory blood pressure monitoring and clinical characteristics of the true and white coat resistant hypertension.
    Veglio, F
    Rabbia, F
    Riva, P
    Martini, G
    Genova, GC
    di Cella, SM
    Milan, A
    Chiandussi, L
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 149A - 149A
  • [38] Sibutramine vs placebo: Meta-analysis of mean changes in resting blood pressure in obese patients with hypertension
    Hazenberg, BP
    Wickens, M
    Chong, E
    OBESITY RESEARCH, 2001, 9 : 153S - 153S
  • [39] Increased lipoprotein (a) as an additional factor in the failure to achieve target blood pressure levels and lipid spectrum optimal parameters in patients with arterial hypertension and multifocal atherosclerosis
    Vedenskaya, S. S.
    Smolenskaya, O. G.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2024, 20 (04)
  • [40] Blood pressure and lipid levels of hypertensive patients with dyslipemia and/or diabetes
    Ocete-Alcalde, Ma. I.
    Garcia-Peñalver, E.
    Salguero, A. J. Martin
    Jimenez-Lopez, P.
    De Cruz-Benayas, Ma. A.
    Maldonado-Martin, A.
    Gil-Extremera, B.
    JOURNAL OF HYPERTENSION, 2006, 24 : S395 - S395
12345